Ionis Pharmaceuticals, Inc.
METHODS OF MODULATING ANTISENSE ACTIVITY

Abstract:

Disclosed herein are methods for increasing antisense activity by modulating EGFR. In certain embodiments, a compound comprising an antisense oligonucleotide is co-administered with an EGFR modulator.